Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELOCTATE® safely and effectively. See full prescribing information for ELOCTATE.ELOCTATE® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injectionInitial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-other
ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: On-demand treatment and control of bleeding episodes, Perioperative management of bleeding, Routine prophylaxis to reduce the frequency of bleeding episodes. Limitation of Use ELOCTATE is not indicated for the treatment of von Willebrand disease.
- generic_name
- antihemophilic factor (recombinant), fc fusion protein
- brand_name
- STERILE WATER
- product_names
- Antihemophilic Factor (Recombinant), Fc Fusion Protein, STERILE WATER
- ndc
- 71104-801, 71104-802, 71104-803, 71104-804, 71104-805, 71104-806, 71104-807, 71104-808, 71104-809, 71104-810, 71104-801-01, 71104-483, 71104-483-08, 71104-035, 71104-035-01, 71104-802-01, 71104-484, 71104-484-08, 71104-803-01, 71104-485, 71104-485-08, 71104-804-01, 71104-486, 71104-486-08, 71104-805-01, 71104-487, 71104-487-08, 71104-806-01, 71104-488, 71104-488-08, 71104-807-01, 71104-489, 71104-489-08, 71104-808-01, 71104-490, 71104-490-08, 71104-809-01, 71104-491, 71104-491-08, 71104-810-01, 71104-492, 71104-492-08
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en